Indaptus Therapeutics, Inc. - INDP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$1.15M
QoQ value delta ($000)
+$1.023M (+805.51%)
Implied price effect (QoQ)
+66.12%
Shares
Total shares
384,996
QoQ shares delta
+314,365 (+445.08%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (INDP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 9 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
HRT FINANCIAL LP 618 206,077 0.0%
GEODE CAPITAL MANAGEMENT, LLC 169 56,470 0.0%
JANE STREET GROUP, LLC 161 53,811 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 100 33,652 0.0%
VANGUARD FIDUCIARY TRUST CO 41 13,967 0.0%
MILLENNIUM MANAGEMENT LLC 34 11,586 0.0%
MORGAN STANLEY 26 8,936 0.0%
UBS Group AG 1 478 0.0%
CWM, LLC 0 2 0.0%
SBI Securities Co., Ltd. 0 17 0.0%